| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |





From the Scott Department of Urology,* Department of Pathology,
Department of Human and Molecular Genetics,
Department of Molecular and Cellular Biology, Department of Radiology,¶ Baylor College of Medicine,|| Houston, Texas USA; and the The Sanger Center,
Wellcome Trust Genome Campus, Cambridgeshire, United Kingdom
Using LoxP/Cre technology, we generated a knockout mouse homozygous for a null mutation in exon 2 of Cav1. In male Cav1-/- animals, we observed a dramatic increase in the incidence of urinary calcium stone formation. In 5-month-old male mice, the incidence of early urinary calculi was 67% in Cav1-/- mice compared to 19% in Cav1+/+ animals. Frank stone formation was observed in 13% of Cav1-/- males but was not seen in Cav1+/+ mice. Urine calcium concentration was significantly higher in Cav1-/- male mice compared to Cav1+/+ mice. In Cav1-/- mice, distal convoluted tubule cells were completely devoid of Cav1 and the localization of plasma membrane calcium ATPase was disrupted. Functional studies confirmed that active calcium absorption was significantly reduced in Cav1-/- compared to Cav1+/+ male mice. These results demonstrate that disruption of the Cav1 gene promotes the progressive steps required for urinary calcium stone formation and establish a new mouse model for urinary stone disease.
This article has been cited by other articles:
![]() |
A. Garg and A. K. Agarwal Caveolin-1: A New Locus for Human Lipodystrophy J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1183 - 1185. [Full Text] [PDF] |
||||
![]() |
C. A. Kim, M. Delepine, E. Boutet, H. El Mourabit, S. Le Lay, M. Meier, M. Nemani, E. Bridel, C. C. Leite, D. R. Bertola, et al. Association of a Homozygous Nonsense Caveolin-1 Mutation with Berardinelli-Seip Congenital Lipodystrophy J. Clin. Endocrinol. Metab., April 1, 2008; 93(4): 1129 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Tahir, G. Yang, A. A. Goltsov, M. Watanabe, K.-i. Tabata, J. Addai, E. M. A. Fattah, D. Kadmon, and T. C. Thompson Tumor Cell-Secreted Caveolin-1 Has Proangiogenic Activities in Prostate Cancer Cancer Res., February 1, 2008; 68(3): 731 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Predescu, D. N. Predescu, and A. B. Malik Molecular determinants of endothelial transcytosis and their role in endothelial permeability Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L823 - L842. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Ayala, H. Dai, S. A. Tahir, R. Li, T. Timme, M. Ittmann, A. Frolov, T. M. Wheeler, D. Rowley, and T. C. Thompson Stromal antiapoptotic paracrine loop in perineural invasion of prostatic carcinoma. Cancer Res., May 15, 2006; 66(10): 5159 - 5164. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Valasek, J. Weng, P. W. Shaul, R. G. W. Anderson, and J. J. Repa Caveolin-1 Is Not Required for Murine Intestinal Cholesterol Transport J. Biol. Chem., July 29, 2005; 280(30): 28103 - 28109. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. W. Moe and O. Bonny Genetic Hypercalciuria J. Am. Soc. Nephrol., March 1, 2005; 16(3): 729 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Trujillo, V. Ramirez, J. Perez, I. Torre-Villalvazo, N. Torres, A. R. Tovar, R. M. Munoz, N. Uribe, G. Gamba, and N. A. Bobadilla Renal protection by a soy diet in obese Zucker rats is associated with restoration of nitric oxide generation Am J Physiol Renal Physiol, January 1, 2005; 288(1): F108 - F116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Cohen, R. Hnasko, W. Schubert, and M. P. Lisanti Role of Caveolae and Caveolins in Health and Disease Physiol Rev, October 1, 2004; 84(4): 1341 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hnasko and M. P. Lisanti The Biology of Caveolae: Lessons from Caveolin Knockout Mice and Implications for Human Disease Mol. Interv., December 1, 2003; 3(8): 445 - 464. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |